Resource Centers
- Cost -- Not Evidence -- Driving Shift in Cancer Screening
- U.S. Medicare to Tighten Rules for Private Plans
- Both Researchers and Journals are to Blame for Inconsistent Disclosure of Conflicts of Interest
- Recalls & Warnings Etanercept Gets Black Box Warning for TB Risk
- FDA Safety Changes: Aredia, Avalide, Biaxin, Doryx, Monodox
- FDA Approvals: Rotarix and PegIntron/Rebetol
Business of Medicine Journals
Medscape Community Resources
- Congress Passes Genetic Privacy Bill
- Perspective: Carotid Stenting and the History of Disruptive Technology in Vascular Surgery
- Last Call for Performance Enhancers: Richard Pound on Major League Baseball, the Olympics, and Gene Doping
- Regional Anesthesia, Compression, and Aspirin Is the Safest Form of Prophylaxis for Hip and Knee Arthroplasty
POLL
According to a recent poll in Nature of 1400 academic scientists (70% from the United States), 20% reported nonmedical use of cognitive performance–enhancing drugs such as Ritalin, Provigil, and Inderal. Do you think a similar problem exists or does not exist among clinicians?
Business of Medicine CME
- Critical Updates: The Role of Atherosclerosis, Hypertension and Diabetes in Cardiovascular Disease: Call to Action for the Cardiologist
- Tics and Tourette Syndrome: A Clinical Review
- The Skinny on Weight Loss Supplements: Fact or Fantasy?
- Highlights of the American Academy of Allergy, Asthma & Immunology 2008 Annual Meeting
- A 33-year-old Woman with Sudden-Onset Severe Headache and Vomiting
